parafarmer
05-24-2006, 01:29 PM
Marijuana-derived Drug Suppresses Bladder Pain In Animal Models
This Article
Also Appears In
Pain / Anesthetics
Main Category: Urology / Nephrology News
Article Date: 22 May 2006 - 6:00am (PDT)
IP 751, a potent synthetic analog of a metabolite of THC -the principal active ingredient of marijuana - effectively suppresses pain in hypersensitive bladder disorders such as interstitial cystitis (IC), according to animal model study results presented today at the annual meeting of the American Urological Association.
IP 751 is a potent anti-inflammatory and a powerful analgesic, although the mechanisms by which it works are unknown. However, since the drug is insoluble in water, its administration directly into the bladder is difficult.
For the study, researchers at the University of Pittsburgh School of Medicine addressed the hydrophobic properties of IP 751 by introducing the drug into a liposome, a tiny sac surrounded by fatty acids, allowing for the drug to be introduced directly into the bladders of rat models of varying degrees of bladder inflammation. IP 751 significantly suppressed bladder overactivity in both animal models. Bladder overactivity is the underlying cause of irritation and pain in the bladder.
more:
http://www.medicalnewstoday.com/medicalnews.php?newsid=43785&nfid=rssfeeds
This Article
Also Appears In
Pain / Anesthetics
Main Category: Urology / Nephrology News
Article Date: 22 May 2006 - 6:00am (PDT)
IP 751, a potent synthetic analog of a metabolite of THC -the principal active ingredient of marijuana - effectively suppresses pain in hypersensitive bladder disorders such as interstitial cystitis (IC), according to animal model study results presented today at the annual meeting of the American Urological Association.
IP 751 is a potent anti-inflammatory and a powerful analgesic, although the mechanisms by which it works are unknown. However, since the drug is insoluble in water, its administration directly into the bladder is difficult.
For the study, researchers at the University of Pittsburgh School of Medicine addressed the hydrophobic properties of IP 751 by introducing the drug into a liposome, a tiny sac surrounded by fatty acids, allowing for the drug to be introduced directly into the bladders of rat models of varying degrees of bladder inflammation. IP 751 significantly suppressed bladder overactivity in both animal models. Bladder overactivity is the underlying cause of irritation and pain in the bladder.
more:
http://www.medicalnewstoday.com/medicalnews.php?newsid=43785&nfid=rssfeeds